Bidirectional binding of invariant chain peptides to an MHC class II molecule

T-cell recognition of peptides bound to MHC class II (MHCII) molecules is a central event in cell-mediated adaptive immunity. The current paradigm holds that prebound class II-associated invariant chain peptides (CLIP) and all subsequent antigens maintain a canonical orientation in the MHCII binding groove. Here we provide evidence for MHCII-bound CLIP inversion. NMR spectroscopy demonstrates that the interconversion from the canonical to the inverse alignment is a dynamic process, and X-ray crystallography shows that conserved MHC residues form a hydrogen bond network with the peptide backbone in both orientations. The natural catalyst HLA-DM accelerates peptide reorientation and the exchange of either canonically or inversely bound CLIP against antigenic peptide. Thus, noncanonical MHC-CLIP displays the hallmarks of a structurally and functionally intact antigen-presenting complex.

[1]  H. Ploegh,et al.  Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization , 2004, Nature Immunology.

[2]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[3]  The solution structure of a class II major histocompatibility complex superantigen binding domain. , 1997, Biochemical and biophysical research communications.

[4]  K. Sakaguchi,et al.  Two-dimensional nuclear magnetic resonance analysis of a labeled peptide bound to a class II major histocompatibility complex molecule. , 1993, Journal of molecular biology.

[5]  Vladimir Brusic,et al.  Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research , 2008, BMC Bioinformatics.

[6]  C. Thoburn,et al.  Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  R. Germain,et al.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy , 1994, The Journal of experimental medicine.

[8]  Zheng Pu,et al.  Amino-Terminal Flanking Residues Determine the Conformation of a Peptide–Class II MHC Complex1 , 2006, The Journal of Immunology.

[9]  L. Stern,et al.  Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro. , 1999, Protein expression and purification.

[10]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[11]  Roland Martin,et al.  Structure of a human autoimmune TCR bound to a myelin basic protein self‐peptide and a multiple sclerosis‐associated MHC class II molecule , 2005, The EMBO journal.

[12]  Robyn L Stanfield,et al.  How TCRs bind MHCs, peptides, and coreceptors. , 2006, Annual review of immunology.

[13]  P. Marrack,et al.  Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register , 2010, Proceedings of the National Academy of Sciences.

[14]  M. Hoshino,et al.  Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. , 2002, Nature structural biology.

[15]  M. Bolognesi,et al.  Fibrillar vs crystalline full-length beta-2-microglobulin studied by high-resolution solid-state NMR spectroscopy. , 2010, Journal of the American Chemical Society.

[16]  Bernd Rupp,et al.  Anchor Side Chains of Short Peptide Fragments Trigger Ligand-Exchange of Class II MHC Molecules , 2008, PloS one.

[17]  J. Harding,et al.  Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression , 2005, Immunological reviews.

[18]  Jennifer Maynard,et al.  Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. , 2005, Immunity.

[19]  Eric O Long,et al.  Two forms of the la antigen-associated invariant chain result from alternative initiations at two in-phase AUGs , 1986, Cell.

[20]  David M. Kranz,et al.  Solution mapping of T cell receptor docking footprints on peptide-MHC , 2007, Proceedings of the National Academy of Sciences.

[21]  K. Wucherpfennig,et al.  Unconventional topology of self peptide–major histocompatibility complex binding by a human autoimmune T cell receptor , 2005, Nature Immunology.

[22]  E. Unanue,et al.  T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. , 2004, Immunity.

[23]  D. Wiley,et al.  Antigenic peptide binding by class I and class II histocompatibility proteins. , 1994, Behring Institute Mitteilungen.

[24]  L. Mitschang,et al.  A xenon-129 biosensor for monitoring MHC-peptide interactions. , 2009, Angewandte Chemie.

[25]  E. Unanue,et al.  Conformational isomers of a peptide–class II major histocompatibility complex , 2005, Immunological reviews.

[26]  A. Smolyar,et al.  The crystal structure of a T cell receptor in complex with peptide and MHC class II. , 1999, Science.

[27]  Ian A Wilson,et al.  Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif. , 2003, Journal of molecular biology.

[28]  D. Mueller.  Mechanisms maintaining peripheral tolerance , 2010, Nature Immunology.

[29]  E. Bergseng,et al.  Complexes of Two Cohorts of CLIP Peptides and HLA-DQ2 of the Autoimmune DR3-DQ2 Haplotype Are Poor Substrates for HLA-DM1 , 2008, The Journal of Immunology.

[30]  John Sidney,et al.  A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach , 2008, PLoS Comput. Biol..

[31]  A. Rudensky,et al.  The lysosomal cysteine proteases in MHC class II antigen presentation , 2005, Immunological reviews.

[32]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[33]  M. Davis,et al.  Conformational isomers of a class II MHC-peptide complex in solution. , 1999, Journal of molecular biology.

[34]  Hidde L. Ploegh,et al.  The known unknowns of antigen processing and presentation , 2008, Nature Reviews Immunology.